Response to the letter to the editor: Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant .
作者信息
Salama Ehab A, Elgammal Yehia, Wijeratne Aruna, Lanman Nadia A, Utturkar Sagar M, Farhangian Atena, Li Jianing, Meunier Brigitte, Hazbun Tony R, Seleem Mohamed N
机构信息
Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
Center for One Health Research, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
出版信息
Emerg Microbes Infect. 2024 Dec;13(1):2396869. doi: 10.1080/22221751.2024.2396869. Epub 2024 Sep 8.
Abstract
摘要
相似文献
1
Response to the letter to the editor: Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant .致编辑的信的回复：兰索拉唑干扰真菌呼吸，并与两性霉素B协同作用对抗多重耐药菌。
Emerg Microbes Infect. 2024 Dec;13(1):2396869. doi: 10.1080/22221751.2024.2396869. Epub 2024 Sep 8.
2
Letter to the editor: lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant .致编辑的信：兰索拉唑干扰真菌呼吸，与两性霉素 B 联合对抗多药耐药性.
Emerg Microbes Infect. 2024 Dec;13(1):2356144. doi: 10.1080/22221751.2024.2356144. Epub 2024 Jun 16.
3
Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant .兰索拉唑干扰真菌呼吸，并与两性霉素B协同作用对抗多重耐药菌。
Emerg Microbes Infect. 2024 Dec;13(1):2322649. doi: 10.1080/22221751.2024.2322649. Epub 2024 Mar 3.
4
Antifungal Susceptibility of the Emerging Multidrug-Resistant Pathogen Candida auris to Miltefosine Alone and in Combination with Amphotericin B.新兴多重耐药病原体耳念珠菌对米替福新单药及与两性霉素B联合使用的抗真菌药敏性
Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.02063-19.
5
Candida auris and multidrug resistance: Defining the new normal.耳念珠菌和多重耐药性：定义新常态。
Fungal Genet Biol. 2019 Oct;131:103243. doi: 10.1016/j.fgb.2019.103243. Epub 2019 Jun 20.
6
Overcoming amphotericin B resistance in using the antiemetic drug rolapitant.使用止吐药洛派丁胺克服两性霉素 B 耐药性。
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0055624. doi: 10.1128/aac.00556-24. Epub 2024 Oct 10.
7
Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak.针对来自纽约疫情的多重耐药耳念珠菌分离株的抗真菌药物联合评估
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02195-19.
8
Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.θ-防御素对多种耐药性念珠菌属种的抗真菌效力和作用机制。
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00111-18. Print 2018 Jun.
9
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.新兴病原体耳念珠菌：生长表型、毒力因子、抗真菌药物活性以及新型葡聚糖合成抑制剂SCY-078对生长形态和生物膜形成的影响
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02396-16. Print 2017 May.
10
The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris.双组分应答调节子 Ssk1 和丝裂原活化蛋白激酶 Hog1 控制新型致病真菌耳念珠菌的抗真菌药物耐药性和细胞壁结构。
mSphere. 2020 Oct 14;5(5):e00973-20. doi: 10.1128/mSphere.00973-20.
本文引用的文献
1
Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant .兰索拉唑干扰真菌呼吸，并与两性霉素B协同作用对抗多重耐药菌。
Emerg Microbes Infect. 2024 Dec;13(1):2322649. doi: 10.1080/22221751.2024.2322649. Epub 2024 Mar 3.
2
interactions of proton pump inhibitors and azoles against pathogenic fungi.质子泵抑制剂与唑类药物对致病性真菌的相互作用。
Front Cell Infect Microbiol. 2024 Jan 17;14:1296151. doi: 10.3389/fcimb.2024.1296151. eCollection 2024.
3
Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers.联合与征服：锰协同抗 TGF-β/PD-L1 双特异性抗体 YM101 克服非炎症性癌症的免疫治疗耐药性。
J Hematol Oncol. 2021 Sep 15;14(1):146. doi: 10.1186/s13045-021-01155-6.
4
Lansoprazole is an antituberculous prodrug targeting cytochrome bc1.兰索拉唑是一种靶向细胞色素bc1的抗结核前体药物。
Nat Commun. 2015 Jul 9;6:7659. doi: 10.1038/ncomms8659.
Zotero 插件